A basic semen analysis costs around $150 at an independent lab. It is the first test a urologist orders after a couple has spent a year trying to conceive. It is also the test most likely to get kicked back by an insurer.
The American Urological Association reports that a male factor shows up in roughly 40 to 50 percent of infertile couples. In a meaningful share of those cases, the male issue is the only identifiable one. The cheapest diagnostic in the fertility workup is the one health plans routinely refuse to cover. That refusal follows a specific billing history.
What the test actually measures
A standard semen analysis looks at four things: sperm count, concentration, motility, and morphology. The World Health Organization publishes reference ranges for each. The test is cheap, noninvasive, and has anchored male evaluation for decades. The American Urological Association and the American Society for Reproductive Medicine both recommend evaluating the male partner at the start of any infertility workup.
The clinical case is clear. The reimbursement structure has not caught up. Many health plans treat infertility services as an excluded benefit category. A woman's first evaluation often sits inside routine gynecological care, which insurers process as standard medical care. A man has no equivalent routine visit. There is no annual male reproductive checkup. His first test falls outside the coverage umbrella by default.
Insurance built fertility benefits around women
Massachusetts passed the first state infertility coverage mandate in 1987. The state laws that followed were written in a context where infertility treatment meant female reproductive endocrinology, ovulation induction, and IVF. Male factor existed in the research. It never got the same legislative attention.
State mandates still leave big gaps. Most large employers self-fund their health plans, which moves them under the federal Employee Retirement Income Security Act and outside state insurance mandates. A man in a state with strong infertility coverage can still get a denial if his employer self-funds. That single fact explains more coverage variation than almost any other feature of the system.
There is a cultural layer too. Women get routed into annual gynecological visits from early adulthood. Providers ask reproductive health questions, order tests, and process claims under standard medical benefits. Men do not have that path. The first reproductive health conversation for many men is the one where they discover their insurance does not think they have a reproductive health category.
The diagnosis code that decides who pays
The billing code for a basic semen analysis is 89310. Insurers look at two things when they process the claim. The procedure code tells them what was done. The diagnosis code tells them why.
The diagnosis coding system, ICD-10, contains N46 for male infertility and N97 for female infertility. Both codes exist. What matters is which one gets attached to the lab order.
If the ordering provider attaches a code for a suspected medical condition, like a varicocele or testicular pain, the claim may process as covered diagnostic care. If the provider attaches N46, the claim routes through the infertility exclusion. The test is identical. The diagnosis code changes the coverage.
This is why two men at the same clinic can get different answers from the same insurer. Asking your urologist how they plan to code the test, and what denials they typically see under your plan, is one of the most useful questions you can ask before the lab draws the sample.
The denial math
Cash prices for a standard semen analysis vary. Independent labs often charge between $50 and $150. Hospital-affiliated labs sometimes bill several hundred dollars once collection and processing fees are added. At-home collection kits have pushed entry-level pricing down, but those kits often measure count and motility while giving less detail on morphology.
The coverage gap has a behavioral cost too. Some men delay testing because they assume any fertility-related test will be denied, or because the process feels like an admission of a problem. By the time some men get tested, months have passed and the couple has already spent money on treatments that may not address the actual issue.
The denial of a $150 test is expensive because of what happens without the information it provides. Insurers that exclude the basic male test may still pay for female diagnostic procedures, medication, and sometimes IVF cycles. The math is backwards. The cheapest diagnostic in the fertility workup is the one most likely to be denied, while the most expensive treatments are the ones coverage is designed around.
Reproductive specialists have argued for years that evaluating both partners from the start is cheaper overall, because it prevents unnecessary cycles and directs resources to the actual problem. Payers ignore that guidance when they route semen analysis to the exclusion.
How to check your coverage before the bill arrives
A few steps can tell you where you stand before you schedule anything.
- Pull your plan's Summary of Benefits and Coverage and search for the words infertility and diagnostic services.
- Call the insurer's member line and ask how CPT 89310 would be covered under different diagnosis codes. Write down the reference number and the representative's name.
- Ask the ordering urologist how they plan to code the test and whether they see denials or approvals under your plan.
- If you get a denial, file a written appeal. Include a note from your doctor explaining why the test is medically necessary. Denials for cheap tests are the ones most likely to get overturned.
These steps will not change a plan that excludes infertility across the board. They tell you where you stand before the bill arrives.
What could change the category
At-home testing and direct-to-consumer labs are making the basic test cheaper and easier to obtain. A man can now get a preliminary result at home, then seek a formal lab confirmation if something looks off. The payer still faces the same category problem, but the entry point is shifting.
Telehealth urology is changing the referral path too. Men can now get a semen analysis ordered through a telehealth visit, which lowers the barrier. The insurance category has not caught up. The codes and exclusions are older than the business models.
Employer-sponsored fertility benefits are expanding. Several large employers now list male diagnostic testing as a covered line item alongside female coverage. The gap may close for a simpler reason. Denying a $150 test while paying for downstream treatment is financially irrational.
The denial traces to a billing category written before male fertility got the same attention. The fix is simpler than a new test. Payers need to treat a cheap diagnostic as a diagnostic. Knowing where the denial comes from tells you where to push.
This content is for educational purposes only and is not medical advice. Oakman products are designed for physical comfort and cooling. They make no claims about fertility, sperm quality, or hormone levels. Consult a healthcare professional for personalized advice.
Frequently asked questions
why does insurance deny a semen analysis
Many health plans classify fertility services as an excluded benefit category. A basic semen analysis gets routed through that exclusion, especially when the provider attaches the male infertility diagnosis code N46 rather than a code for a suspected medical condition like a varicocele or testicular pain.
how much does a semen analysis cost without insurance
Independent labs often charge between $50 and $150 for a standard semen analysis. Hospital-affiliated labs can bill several hundred dollars once collection and processing fees are added. At-home collection kits can be cheaper but often measure fewer parameters.
how can i get a semen analysis covered by insurance
Check your Summary of Benefits and Coverage for infertility exclusions. Call your insurer and ask how CPT code 89310 is covered under different diagnosis codes. Ask your urologist how they plan to code the test, and if you get a denial, file a written appeal with a note from your doctor explaining medical necessity.
does male fertility testing fall under health insurance benefits
It depends on the plan and the diagnosis code. A male factor is present in roughly 40 to 50 percent of infertile couples, yet male diagnostic testing often falls outside routine coverage. Some employer plans now list male diagnostic testing as a covered line item, while self-funded plans remain exempt from state fertility mandates.